CCS Healthcare acquires Propyless

CCS Healthcare has entered into an agreement with Merck Sharp & Dohme to acquire the pharmaceutical skin care product and trademark Propyless. Propyless is a lotion, based on active substance propylene glycol, used for dry skin, atopic dermatitis and psoriasis.

DealsNorth AmericaUSBriefs